A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE4
HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
- Status
- COMPLETED
- Phase
- N/A
Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents
- Status
- WITHDRAWN
- Phase
- N/A
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage
- Status
- UNKNOWN
- Phase
- NA
NANOTECH RCC Biomarkers
- Status
- COMPLETED
- Phase
- N/A
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)
- Status
- COMPLETED
- Phase
- PHASE3
Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors
- Status
- COMPLETED
- Phase
- N/A
Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy
- Status
- UNKNOWN
- Phase
- NA
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1